Downregulation of both EGFR and ErbB3 improves the cellular response to pemetrexed in an established pemetrexedresistant lung adenocarcinoma A549 cell line
Document Type: Research Article
Affiliations: 1: Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266003, P.R. China 2: Central Laboratory, The Affiliated Hospital of Qingdao University, Qingdao 266003, P.R. China 3: Department of Medicine, The Commercial Workers' Hospital of Qingdao, Qingdao 266011, P.R. China
Publication date: January 1, 2014
- Oncology Reports is a monthly, peer-reviewed journal devoted to the publication of high quality original studies and reviews concerning a broad and comprehensive view of fundamental and applied research in oncology, focusing on carcinogenesis, metastasis and epidemiology.
The journal is published in both print and electronic format.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites